IMG_2403

IMG_2429

導生爬山

IMG_2403

1/8

If you have questions for us, please don't hesitate to leave your message.

Events in R411

20210220

Welcome 呂韋萱(陽明醫技) join us for undergraduate projects

20200920

Welcome 陳一華(陽明醫學) join us for undergraduate projects

20200815

Welcome 周壬渼、蔡若翎 join us

20200731

Welcome 張琳翔、張庭偉、陳一華、林得鴻for summer internship

20200701

Welcome陶定雨(陽明生科)、劉子晴(陽明醫技)、陳怡秀(陽明醫技)、吳思賢(陽明醫技) join us for undergraduate projects

20200226

Published in Journal of Virology (identify new EBV strains)

20200210

Welcome 林家安(陽明醫技)、莊筑甯(陽明醫技)、余麗文(陽明醫技)、賴金承(陽明醫學) join us for undergraduate projects

20200120

Welcome TIGP PhD student Ivonne Lee join us

20191230

Welcome 洪若寧(陽明醫技) join us

20191105

Welcome TIGP PhD student Ivonne Lee! (rotation)

20191026-31

International collaboration with Applied science and Pharmaceutical departments of TDTU (孫得勝大學)@ Vietnam.

20191001

The opening of R411's Website!

20190928

Whole Lab's database complete

20190930

Published in PloS One (functions of miRNA in EBV-transformed B cells isolated from patients).

20190906

Published in Nature Microbiology (ncRNA EBER regulates viral lytic replication and its effects on the environmental cells).

20190901

Welcome 毛翎, queen of 3D culture.

20190801

Welcome 李晉豪、蘇沛瑜、ChiaChia

2019July

Welcome summer students

Welcome international students

20190301

Welcome 張舒雅(陽明醫技)

20190201

Published in Journal of Virology (EBV+ B cell movement).

20181101

Published in Plos Pathogens (EBV vaccine)

20180901

Welcome 翁立洋、洪瑄茌

20180815

Eventually our lab is ready to be used.

20180701

Welcome 5 Summer students

20180501

Congratulation! We won the MOST Young Scholar Fellowship! (哥倫布計畫得主)

20180301

Published in Nucleic Acids Research (new ORF of EBV)

Who we are?

We are a very strong team for studying the viral genetics and the pathogenic roles of the giant virus. We use Epstein-Barr virus (EBV) as model. Our group leader, Dr. Ming-Han Tsai (蔡明翰) is exactly the person who had successfully constructed the five standard EBV strains (total 7 strains) in the world (including all the carcinoma EBV strains). Meanwhile, our PI has the strong collaboration with Prof. Dr. Delecluse at DKFZ/Germany, who established the elegant system to modify the EBV viral genome.

We have strong collaboration with different research groups and hospitals in Taiwan and globally and wish to eradicate the cancers caused by EBV in the next decades. At first, we are focusing on the pathogenic roles of EBV in gastric cancer and we will expand our research toward other EBV-associated carcinomas. Importantly, EBV is the last major human tumor virus that is still barely understood; so far we still don't have drugs or vaccines against EBV.

Due to the strong techniques for constructing giant DNA virus, we are also genetically modifying these giant DNA viruses for different applications and seeking for the opportunities for the bio-pharmaceutical businesses.

Our researches are kindly supported by MOST Young Scholar Fellowship for 5 years. We sincerely invite the highly motivated students to join our research team and enjoy the researches together!